EMPI FDA Approval NDA 021486

NDA 021486

EMPI

FDA Drug Application

Application #021486

Documents

Review2007-06-04
Letter2004-10-29
Label2004-11-01

Application Sponsors

NDA 021486EMPI

Marketing Status

Discontinued001

Application Products

001SOLUTION;IONTOPHORESIS, TOPICAL0.01MG/ML;2%0LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEEPINEPHRINE; LIDOCAINE HYDROCHLORIDE

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP2004-10-26STANDARD

Submissions Property Types

ORIG1Null0

CDER Filings

EMPI
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21486
            [companyName] => EMPI
            [docInserts] => ["",""]
            [products] => [{"drugName":"LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE","activeIngredients":"EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","strength":"0.01MG\/ML;2%","dosageForm":"SOLUTION;IONTOPHORESIS, TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"10\/26\/2004","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/21486lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE","submission":"EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","actionType":"0.01MG\/ML;2%","submissionClassification":"SOLUTION;IONTOPHORESIS, TOPICAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2004-10-26
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.